Global Tinea Pedis Treatment Market Insights, Forecast to 2028

TABLE OF CONTENTS

1 Study Coverage

• 1.1 Tinea Pedis Treatment Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global Tinea Pedis Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
  • 1.2.2 Interdigital
  • 1.2.3 Vesicular
• 1.3 Market by Application
  • 1.3.1 Global Tinea Pedis Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
  • 1.3.2 Hospital Pharmacies
  • 1.3.3 Retail Pharmacies
  • 1.3.4 Online Pharmacies
  • 1.3.5 Drug Stores
  • 1.3.6 Others
• 1.4 Study Objectives
• 1.5 Years Considered

2 Executive Summary

• 2.1 Global Tinea Pedis Treatment Sales Estimates and Forecasts 2017-2028
• 2.2 Global Tinea Pedis Treatment Revenue Estimates and Forecasts 2017-2028
• 2.3 Global Tinea Pedis Treatment Revenue by Region: 2017 VS 2021 VS 2028
• 2.4 Global Tinea Pedis Treatment Sales by Region
  • 2.4.1 Global Tinea Pedis Treatment Sales by Region (2017-2022)
  • 2.4.2 Global Sales Tinea Pedis Treatment by Region (2023-2028)
• 2.5 Global Tinea Pedis Treatment Revenue by Region
  • 2.5.1 Global Tinea Pedis Treatment Revenue by Region (2017-2022)
  • 2.5.2 Global Tinea Pedis Treatment Revenue by Region (2023-2028)
• 2.6 North America
• 2.7 Europe
• 2.8 Asia-Pacific
• 2.9 Latin America
• 2.10 Middle East & Africa

3 Competition by Manufacturers

• 3.1 Global Tinea Pedis Treatment Sales by Manufacturers
  • 3.1.1 Global Top Tinea Pedis Treatment Manufacturers by Sales (2017-2022)
  • 3.1.2 Global Tinea Pedis Treatment Sales Market Share by Manufacturers (2017-2022)
  • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Tinea Pedis Treatment in 2021
• 3.2 Global Tinea Pedis Treatment Revenue by Manufacturers
  • 3.2.1 Global Tinea Pedis Treatment Revenue by Manufacturers (2017-2022)
  • 3.2.2 Global Tinea Pedis Treatment Revenue Market Share by Manufacturers (2017-2022)
  • 3.2.3 Global Top 10 and Top 5 Companies by Tinea Pedis Treatment Revenue in 2021
• 3.3 Global Tinea Pedis Treatment Sales Price by Manufacturers (2017-2022)
• 3.4 Analysis of Competitive Landscape
  • 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Tinea Pedis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.4.3 Global Tinea Pedis Treatment Manufacturers Geographical Distribution
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Global Tinea Pedis Treatment Sales by Type
  • 4.1.1 Global Tinea Pedis Treatment Historical Sales by Type (2017-2022)
  • 4.1.2 Global Tinea Pedis Treatment Forecasted Sales by Type (2023-2028)
  • 4.1.3 Global Tinea Pedis Treatment Sales Market Share by Type (2017-2028)
• 4.2 Global Tinea Pedis Treatment Revenue by Type
  • 4.2.1 Global Tinea Pedis Treatment Historical Revenue by Type (2017-2022)
  • 4.2.2 Global Tinea Pedis Treatment Forecasted Revenue by Type (2023-2028)
  • 4.2.3 Global Tinea Pedis Treatment Revenue Market Share by Type (2017-2028)
• 4.3 Global Tinea Pedis Treatment Price by Type
  • 4.3.1 Global Tinea Pedis Treatment Price by Type (2017-2022)
  • 4.3.2 Global Tinea Pedis Treatment Price Forecast by Type (2023-2028)

5 Market Size by Application

• 5.1 Global Tinea Pedis Treatment Sales by Application
  • 5.1.1 Global Tinea Pedis Treatment Historical Sales by Application (2017-2022)
  • 5.1.2 Global Tinea Pedis Treatment Forecasted Sales by Application (2023-2028)
  • 5.1.3 Global Tinea Pedis Treatment Sales Market Share by Application (2017-2028)
• 5.2 Global Tinea Pedis Treatment Revenue by Application
  • 5.2.1 Global Tinea Pedis Treatment Historical Revenue by Application (2017-2022)
  • 5.2.2 Global Tinea Pedis Treatment Forecasted Revenue by Application (2023-2028)
  • 5.2.3 Global Tinea Pedis Treatment Revenue Market Share by Application (2017-2028)
• 5.3 Global Tinea Pedis Treatment Price by Application
  • 5.3.1 Global Tinea Pedis Treatment Price by Application (2017-2022)
  • 5.3.2 Global Tinea Pedis Treatment Price Forecast by Application (2023-2028)

6 North America

• 6.1 North America Tinea Pedis Treatment Market Size by Type
  • 6.1.1 North America Tinea Pedis Treatment Sales by Type (2017-2028)
  • 6.1.2 North America Tinea Pedis Treatment Revenue by Type (2017-2028)
• 6.2 North America Tinea Pedis Treatment Market Size by Application
  • 6.2.1 North America Tinea Pedis Treatment Sales by Application (2017-2028)
  • 6.2.2 North America Tinea Pedis Treatment Revenue by Application (2017-2028)
• 6.3 North America Tinea Pedis Treatment Market Size by Country
  • 6.3.1 North America Tinea Pedis Treatment Sales by Country (2017-2028)
  • 6.3.2 North America Tinea Pedis Treatment Revenue by Country (2017-2028)
  • 6.3.3 U.S.
  • 6.3.4 Canada

7 Europe

• 7.1 Europe Tinea Pedis Treatment Market Size by Type
  • 7.1.1 Europe Tinea Pedis Treatment Sales by Type (2017-2028)
  • 7.1.2 Europe Tinea Pedis Treatment Revenue by Type (2017-2028)
• 7.2 Europe Tinea Pedis Treatment Market Size by Application
  • 7.2.1 Europe Tinea Pedis Treatment Sales by Application (2017-2028)
  • 7.2.2 Europe Tinea Pedis Treatment Revenue by Application (2017-2028)
• 7.3 Europe Tinea Pedis Treatment Market Size by Country
  • 7.3.1 Europe Tinea Pedis Treatment Sales by Country (2017-2028)
  • 7.3.2 Europe Tinea Pedis Treatment Revenue by Country (2017-2028)
  • 7.3.3 Germany
  • 7.3.4 France
  • 7.3.5 U.K.
  • 7.3.6 Italy
  • 7.3.7 Russia

8 Asia Pacific

• 8.1 Asia Pacific Tinea Pedis Treatment Market Size by Type
  • 8.1.1 Asia Pacific Tinea Pedis Treatment Sales by Type (2017-2028)
  • 8.1.2 Asia Pacific Tinea Pedis Treatment Revenue by Type (2017-2028)
• 8.2 Asia Pacific Tinea Pedis Treatment Market Size by Application
  • 8.2.1 Asia Pacific Tinea Pedis Treatment Sales by Application (2017-2028)
  • 8.2.2 Asia Pacific Tinea Pedis Treatment Revenue by Application (2017-2028)
• 8.3 Asia Pacific Tinea Pedis Treatment Market Size by Region
  • 8.3.1 Asia Pacific Tinea Pedis Treatment Sales by Region (2017-2028)
  • 8.3.2 Asia Pacific Tinea Pedis Treatment Revenue by Region (2017-2028)
  • 8.3.3 China
  • 8.3.4 Japan
  • 8.3.5 South Korea
  • 8.3.6 India
  • 8.3.7 Australia
  • 8.3.8 Taiwan
  • 8.3.9 Indonesia
  • 8.3.10 Thailand
  • 8.3.11 Malaysia
  • 8.3.12 Philippines

9 Latin America

• 9.1 Latin America Tinea Pedis Treatment Market Size by Type
  • 9.1.1 Latin America Tinea Pedis Treatment Sales by Type (2017-2028)
  • 9.1.2 Latin America Tinea Pedis Treatment Revenue by Type (2017-2028)
• 9.2 Latin America Tinea Pedis Treatment Market Size by Application
  • 9.2.1 Latin America Tinea Pedis Treatment Sales by Application (2017-2028)
  • 9.2.2 Latin America Tinea Pedis Treatment Revenue by Application (2017-2028)
• 9.3 Latin America Tinea Pedis Treatment Market Size by Country
  • 9.3.1 Latin America Tinea Pedis Treatment Sales by Country (2017-2028)
  • 9.3.2 Latin America Tinea Pedis Treatment Revenue by Country (2017-2028)
  • 9.3.3 Mexico
  • 9.3.4 Brazil
  • 9.3.5 Argentina

10 Middle East and Africa

• 10.1 Middle East and Africa Tinea Pedis Treatment Market Size by Type
  • 10.1.1 Middle East and Africa Tinea Pedis Treatment Sales by Type (2017-2028)
  • 10.1.2 Middle East and Africa Tinea Pedis Treatment Revenue by Type (2017-2028)
• 10.2 Middle East and Africa Tinea Pedis Treatment Market Size by Application
  • 10.2.1 Middle East and Africa Tinea Pedis Treatment Sales by Application (2017-2028)
  • 10.2.2 Middle East and Africa Tinea Pedis Treatment Revenue by Application (2017-2028)
• 10.3 Middle East and Africa Tinea Pedis Treatment Market Size by Country
  • 10.3.1 Middle East and Africa Tinea Pedis Treatment Sales by Country (2017-2028)
  • 10.3.2 Middle East and Africa Tinea Pedis Treatment Revenue by Country (2017-2028)
  • 10.3.3 Turkey
  • 10.3.4 Saudi Arabia

11 Company Profiles

• 11.1 GSK
  • 11.1.1 GSK Corporation Information
  • 11.1.2 GSK Overview
  • 11.1.3 GSK Tinea Pedis Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.1.4 GSK Tinea Pedis Treatment Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.1.5 GSK Recent Developments
• 11.2 Exeltis USA
  • 11.2.1 Exeltis USA Corporation Information
  • 11.2.2 Exeltis USA Overview
  • 11.2.3 Exeltis USA Tinea Pedis Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.2.4 Exeltis USA Tinea Pedis Treatment Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.2.5 Exeltis USA Recent Developments
• 11.3 Valeant
  • 11.3.1 Valeant Corporation Information
  • 11.3.2 Valeant Overview
  • 11.3.3 Valeant Tinea Pedis Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.3.4 Valeant Tinea Pedis Treatment Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.3.5 Valeant Recent Developments
• 11.4 Incyte
  • 11.4.1 Incyte Corporation Information
  • 11.4.2 Incyte Overview
  • 11.4.3 Incyte Tinea Pedis Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.4.4 Incyte Tinea Pedis Treatment Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.4.5 Incyte Recent Developments
• 11.5 Celgene
  • 11.5.1 Celgene Corporation Information
  • 11.5.2 Celgene Overview
  • 11.5.3 Celgene Tinea Pedis Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.5.4 Celgene Tinea Pedis Treatment Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.5.5 Celgene Recent Developments
• 11.6 Hisamitsu Pharmaceutical
  • 11.6.1 Hisamitsu Pharmaceutical Corporation Information
  • 11.6.2 Hisamitsu Pharmaceutical Overview
  • 11.6.3 Hisamitsu Pharmaceutical Tinea Pedis Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.6.4 Hisamitsu Pharmaceutical Tinea Pedis Treatment Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.6.5 Hisamitsu Pharmaceutical Recent Developments
• 11.7 NovaBiotics
  • 11.7.1 NovaBiotics Corporation Information
  • 11.7.2 NovaBiotics Overview
  • 11.7.3 NovaBiotics Tinea Pedis Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.7.4 NovaBiotics Tinea Pedis Treatment Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.7.5 NovaBiotics Recent Developments
• 11.8 Elorac
  • 11.8.1 Elorac Corporation Information
  • 11.8.2 Elorac Overview
  • 11.8.3 Elorac Tinea Pedis Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.8.4 Elorac Tinea Pedis Treatment Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.8.5 Elorac Recent Developments
• 11.9 F. Hoffmann-La Roche
  • 11.9.1 F. Hoffmann-La Roche Corporation Information
  • 11.9.2 F. Hoffmann-La Roche Overview
  • 11.9.3 F. Hoffmann-La Roche Tinea Pedis Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.9.4 F. Hoffmann-La Roche Tinea Pedis Treatment Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.9.5 F. Hoffmann-La Roche Recent Developments
• 11.10 Sanofi
  • 11.10.1 Sanofi Corporation Information
  • 11.10.2 Sanofi Overview
  • 11.10.3 Sanofi Tinea Pedis Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.10.4 Sanofi Tinea Pedis Treatment Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.10.5 Sanofi Recent Developments
• 11.11 Teva Pharmaceutical
  • 11.11.1 Teva Pharmaceutical Corporation Information
  • 11.11.2 Teva Pharmaceutical Overview
  • 11.11.3 Teva Pharmaceutical Tinea Pedis Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.11.4 Teva Pharmaceutical Tinea Pedis Treatment Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.11.5 Teva Pharmaceutical Recent Developments

12 Industry Chain and Sales Channels Analysis

• 12.1 Tinea Pedis Treatment Industry Chain Analysis
• 12.2 Tinea Pedis Treatment Key Raw Materials
  • 12.2.1 Key Raw Materials
  • 12.2.2 Raw Materials Key Suppliers
• 12.3 Tinea Pedis Treatment Production Mode & Process
• 12.4 Tinea Pedis Treatment Sales and Marketing
  • 12.4.1 Tinea Pedis Treatment Sales Channels
  • 12.4.2 Tinea Pedis Treatment Distributors
• 12.5 Tinea Pedis Treatment Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

• 13.1 Tinea Pedis Treatment Industry Trends
• 13.2 Tinea Pedis Treatment Market Drivers
• 13.3 Tinea Pedis Treatment Market Challenges
• 13.4 Tinea Pedis Treatment Market Restraints

14 Key Findings in The Global Tinea Pedis Treatment Study

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Author Details
• 15.3 Disclaimer

• Table 1. Global Tinea Pedis Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
• Table 2. Major Manufacturers of Interdigital
• Table 3. Major Manufacturers of Vesicular
• Table 4. Global Tinea Pedis Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
• Table 5. Global Tinea Pedis Treatment Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
• Table 6. Global Tinea Pedis Treatment Sales by Region (2017-2022) & (K MT)
• Table 7. Global Tinea Pedis Treatment Sales Market Share by Region (2017-2022)
• Table 8. Global Tinea Pedis Treatment Sales by Region (2023-2028) & (K MT)
• Table 9. Global Tinea Pedis Treatment Sales Market Share by Region (2023-2028)
• Table 10. Global Tinea Pedis Treatment Revenue by Region (2017-2022) & (US$ Million)
• Table 11. Global Tinea Pedis Treatment Revenue Market Share by Region (2017-2022)
• Table 12. Global Tinea Pedis Treatment Revenue by Region (2023-2028) & (US$ Million)
• Table 13. Global Tinea Pedis Treatment Revenue Market Share by Region (2023-2028)
• Table 14. Global Tinea Pedis Treatment Sales by Manufacturers (2017-2022) & (K MT)
• Table 15. Global Tinea Pedis Treatment Sales Share by Manufacturers (2017-2022)
• Table 16. Global Tinea Pedis Treatment Revenue by Manufacturers (2017-2022) & (US$ Million)
• Table 17. Global Tinea Pedis Treatment Revenue Share by Manufacturers (2017-2022)
• Table 18. Tinea Pedis Treatment Price by Manufacturers (2017-2022) &(USD/MT)
• Table 19. Global Tinea Pedis Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
• Table 20. Global Tinea Pedis Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tinea Pedis Treatment as of 2021)
• Table 21. Tinea Pedis Treatment Manufacturing Base Distribution and Headquarters
• Table 22. Manufacturers Tinea Pedis Treatment Product Offered
• Table 23. Date of Manufacturers Enter into Tinea Pedis Treatment Market
• Table 24. Mergers & Acquisitions, Expansion Plans
• Table 25. Global Tinea Pedis Treatment Sales by Type (2017-2022) & (K MT)
• Table 26. Global Tinea Pedis Treatment Sales by Type (2023-2028) & (K MT)
• Table 27. Global Tinea Pedis Treatment Sales Share by Type (2017-2022)
• Table 28. Global Tinea Pedis Treatment Sales Share by Type (2023-2028)
• Table 29. Global Tinea Pedis Treatment Revenue by Type (2017-2022) & (US$ Million)
• Table 30. Global Tinea Pedis Treatment Revenue by Type (2023-2028) & (US$ Million)
• Table 31. Global Tinea Pedis Treatment Revenue Share by Type (2017-2022)
• Table 32. Global Tinea Pedis Treatment Revenue Share by Type (2023-2028)
• Table 33. Tinea Pedis Treatment Price by Type (2017-2022) & (USD/MT)
• Table 34. Global Tinea Pedis Treatment Price Forecast by Type (2023-2028) & (USD/MT)
• Table 35. Global Tinea Pedis Treatment Sales by Application (2017-2022) & (K MT)
• Table 36. Global Tinea Pedis Treatment Sales by Application (2023-2028) & (K MT)
• Table 37. Global Tinea Pedis Treatment Sales Share by Application (2017-2022)
• Table 38. Global Tinea Pedis Treatment Sales Share by Application (2023-2028)
• Table 39. Global Tinea Pedis Treatment Revenue by Application (2017-2022) & (US$ Million)
• Table 40. Global Tinea Pedis Treatment Revenue by Application (2023-2028) & (US$ Million)
• Table 41. Global Tinea Pedis Treatment Revenue Share by Application (2017-2022)
• Table 42. Global Tinea Pedis Treatment Revenue Share by Application (2023-2028)
• Table 43. Tinea Pedis Treatment Price by Application (2017-2022) & (USD/MT)
• Table 44. Global Tinea Pedis Treatment Price Forecast by Application (2023-2028) & (USD/MT)
• Table 45. North America Tinea Pedis Treatment Sales by Type (2017-2022) & (K MT)
• Table 46. North America Tinea Pedis Treatment Sales by Type (2023-2028) & (K MT)
• Table 47. North America Tinea Pedis Treatment Revenue by Type (2017-2022) & (US$ Million)
• Table 48. North America Tinea Pedis Treatment Revenue by Type (2023-2028) & (US$ Million)
• Table 49. North America Tinea Pedis Treatment Sales by Application (2017-2022) & (K MT)
• Table 50. North America Tinea Pedis Treatment Sales by Application (2023-2028) & (K MT)
• Table 51. North America Tinea Pedis Treatment Revenue by Application (2017-2022) & (US$ Million)
• Table 52. North America Tinea Pedis Treatment Revenue by Application (2023-2028) & (US$ Million)
• Table 53. North America Tinea Pedis Treatment Sales by Country (2017-2022) & (K MT)
• Table 54. North America Tinea Pedis Treatment Sales by Country (2023-2028) & (K MT)
• Table 55. North America Tinea Pedis Treatment Revenue by Country (2017-2022) & (US$ Million)
• Table 56. North America Tinea Pedis Treatment Revenue by Country (2023-2028) & (US$ Million)
• Table 57. Europe Tinea Pedis Treatment Sales by Type (2017-2022) & (K MT)
• Table 58. Europe Tinea Pedis Treatment Sales by Type (2023-2028) & (K MT)
• Table 59. Europe Tinea Pedis Treatment Revenue by Type (2017-2022) & (US$ Million)
• Table 60. Europe Tinea Pedis Treatment Revenue by Type (2023-2028) & (US$ Million)
• Table 61. Europe Tinea Pedis Treatment Sales by Application (2017-2022) & (K MT)
• Table 62. Europe Tinea Pedis Treatment Sales by Application (2023-2028) & (K MT)
• Table 63. Europe Tinea Pedis Treatment Revenue by Application (2017-2022) & (US$ Million)
• Table 64. Europe Tinea Pedis Treatment Revenue by Application (2023-2028) & (US$ Million)
• Table 65. Europe Tinea Pedis Treatment Sales by Country (2017-2022) & (K MT)
• Table 66. Europe Tinea Pedis Treatment Sales by Country (2023-2028) & (K MT)
• Table 67. Europe Tinea Pedis Treatment Revenue by Country (2017-2022) & (US$ Million)
• Table 68. Europe Tinea Pedis Treatment Revenue by Country (2023-2028) & (US$ Million)
• Table 69. Asia Pacific Tinea Pedis Treatment Sales by Type (2017-2022) & (K MT)
• Table 70. Asia Pacific Tinea Pedis Treatment Sales by Type (2023-2028) & (K MT)
• Table 71. Asia Pacific Tinea Pedis Treatment Revenue by Type (2017-2022) & (US$ Million)
• Table 72. Asia Pacific Tinea Pedis Treatment Revenue by Type (2023-2028) & (US$ Million)
• Table 73. Asia Pacific Tinea Pedis Treatment Sales by Application (2017-2022) & (K MT)
• Table 74. Asia Pacific Tinea Pedis Treatment Sales by Application (2023-2028) & (K MT)
• Table 75. Asia Pacific Tinea Pedis Treatment Revenue by Application (2017-2022) & (US$ Million)
• Table 76. Asia Pacific Tinea Pedis Treatment Revenue by Application (2023-2028) & (US$ Million)
• Table 77. Asia Pacific Tinea Pedis Treatment Sales by Region (2017-2022) & (K MT)
• Table 78. Asia Pacific Tinea Pedis Treatment Sales by Region (2023-2028) & (K MT)
• Table 79. Asia Pacific Tinea Pedis Treatment Revenue by Region (2017-2022) & (US$ Million)
• Table 80. Asia Pacific Tinea Pedis Treatment Revenue by Region (2023-2028) & (US$ Million)
• Table 81. Latin America Tinea Pedis Treatment Sales by Type (2017-2022) & (K MT)
• Table 82. Latin America Tinea Pedis Treatment Sales by Type (2023-2028) & (K MT)
• Table 83. Latin America Tinea Pedis Treatment Revenue by Type (2017-2022) & (US$ Million)
• Table 84. Latin America Tinea Pedis Treatment Revenue by Type (2023-2028) & (US$ Million)
• Table 85. Latin America Tinea Pedis Treatment Sales by Application (2017-2022) & (K MT)
• Table 86. Latin America Tinea Pedis Treatment Sales by Application (2023-2028) & (K MT)
• Table 87. Latin America Tinea Pedis Treatment Revenue by Application (2017-2022) & (US$ Million)
• Table 88. Latin America Tinea Pedis Treatment Revenue by Application (2023-2028) & (US$ Million)
• Table 89. Latin America Tinea Pedis Treatment Sales by Country (2017-2022) & (K MT)
• Table 90. Latin America Tinea Pedis Treatment Sales by Country (2023-2028) & (K MT)
• Table 91. Latin America Tinea Pedis Treatment Revenue by Country (2017-2022) & (US$ Million)
• Table 92. Latin America Tinea Pedis Treatment Revenue by Country (2023-2028) & (US$ Million)
• Table 93. Middle East and Africa Tinea Pedis Treatment Sales by Type (2017-2022) & (K MT)
• Table 94. Middle East and Africa Tinea Pedis Treatment Sales by Type (2023-2028) & (K MT)
• Table 95. Middle East and Africa Tinea Pedis Treatment Revenue by Type (2017-2022) & (US$ Million)
• Table 96. Middle East and Africa Tinea Pedis Treatment Revenue by Type (2023-2028) & (US$ Million)
• Table 97. Middle East and Africa Tinea Pedis Treatment Sales by Application (2017-2022) & (K MT)
• Table 98. Middle East and Africa Tinea Pedis Treatment Sales by Application (2023-2028) & (K MT)
• Table 99. Middle East and Africa Tinea Pedis Treatment Revenue by Application (2017-2022) & (US$ Million)
• Table 100. Middle East and Africa Tinea Pedis Treatment Revenue by Application (2023-2028) & (US$ Million)
• Table 101. Middle East and Africa Tinea Pedis Treatment Sales by Country (2017-2022) & (K MT)
• Table 102. Middle East and Africa Tinea Pedis Treatment Sales by Country (2023-2028) & (K MT)
• Table 103. Middle East and Africa Tinea Pedis Treatment Revenue by Country (2017-2022) & (US$ Million)
• Table 104. Middle East and Africa Tinea Pedis Treatment Revenue by Country (2023-2028) & (US$ Million)
• Table 105. GSK Corporation Information
• Table 106. GSK Description and Major Businesses
• Table 107. GSK Tinea Pedis Treatment Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
• Table 108. GSK Tinea Pedis Treatment Product Model Numbers, Pictures, Descriptions and Specifications
• Table 109. GSK Recent Developments
• Table 110. Exeltis USA Corporation Information
• Table 111. Exeltis USA Description and Major Businesses
• Table 112. Exeltis USA Tinea Pedis Treatment Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
• Table 113. Exeltis USA Tinea Pedis Treatment Product Model Numbers, Pictures, Descriptions and Specifications
• Table 114. Exeltis USA Recent Developments
• Table 115. Valeant Corporation Information
• Table 116. Valeant Description and Major Businesses
• Table 117. Valeant Tinea Pedis Treatment Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
• Table 118. Valeant Tinea Pedis Treatment Product Model Numbers, Pictures, Descriptions and Specifications
• Table 119. Valeant Recent Developments
• Table 120. Incyte Corporation Information
• Table 121. Incyte Description and Major Businesses
• Table 122. Incyte Tinea Pedis Treatment Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
• Table 123. Incyte Tinea Pedis Treatment Product Model Numbers, Pictures, Descriptions and Specifications
• Table 124. Incyte Recent Developments
• Table 125. Celgene Corporation Information
• Table 126. Celgene Description and Major Businesses
• Table 127. Celgene Tinea Pedis Treatment Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
• Table 128. Celgene Tinea Pedis Treatment Product Model Numbers, Pictures, Descriptions and Specifications
• Table 129. Celgene Recent Developments
• Table 130. Hisamitsu Pharmaceutical Corporation Information
• Table 131. Hisamitsu Pharmaceutical Description and Major Businesses
• Table 132. Hisamitsu Pharmaceutical Tinea Pedis Treatment Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
• Table 133. Hisamitsu Pharmaceutical Tinea Pedis Treatment Product Model Numbers, Pictures, Descriptions and Specifications
• Table 134. Hisamitsu Pharmaceutical Recent Developments
• Table 135. NovaBiotics Corporation Information
• Table 136. NovaBiotics Description and Major Businesses
• Table 137. NovaBiotics Tinea Pedis Treatment Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
• Table 138. NovaBiotics Tinea Pedis Treatment Product Model Numbers, Pictures, Descriptions and Specifications
• Table 139. NovaBiotics Recent Developments
• Table 140. Elorac Corporation Information
• Table 141. Elorac Description and Major Businesses
• Table 142. Elorac Tinea Pedis Treatment Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
• Table 143. Elorac Tinea Pedis Treatment Product Model Numbers, Pictures, Descriptions and Specifications
• Table 144. Elorac Recent Developments
• Table 145. F. Hoffmann-La Roche Corporation Information
• Table 146. F. Hoffmann-La Roche Description and Major Businesses
• Table 147. F. Hoffmann-La Roche Tinea Pedis Treatment Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
• Table 148. F. Hoffmann-La Roche Tinea Pedis Treatment Product Model Numbers, Pictures, Descriptions and Specifications
• Table 149. F. Hoffmann-La Roche Recent Developments
• Table 150. Sanofi Corporation Information
• Table 151. Sanofi Description and Major Businesses
• Table 152. Sanofi Tinea Pedis Treatment Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
• Table 153. Sanofi Tinea Pedis Treatment Product Model Numbers, Pictures, Descriptions and Specifications
• Table 154. Sanofi Recent Developments
• Table 155. Teva Pharmaceutical Corporation Information
• Table 156. Teva Pharmaceutical Description and Major Businesses
• Table 157. Teva Pharmaceutical Tinea Pedis Treatment Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
• Table 158. Teva Pharmaceutical Tinea Pedis Treatment Product Model Numbers, Pictures, Descriptions and Specifications
• Table 159. Teva Pharmaceutical Recent Developments
• Table 160. Key Raw Materials Lists
• Table 161. Raw Materials Key Suppliers Lists
• Table 162. Tinea Pedis Treatment Distributors List
• Table 163. Tinea Pedis Treatment Customers List
• Table 164. Tinea Pedis Treatment Market Trends
• Table 165. Tinea Pedis Treatment Market Drivers
• Table 166. Tinea Pedis Treatment Market Challenges
• Table 167. Tinea Pedis Treatment Market Restraints
• Table 168. Research Programs/Design for This Report
• Table 169. Key Data Information from Secondary Sources
• Table 170. Key Data Information from Primary Sources

List of Figures

• Figure 1. Tinea Pedis Treatment Product Picture
• Figure 3. Global Tinea Pedis Treatment Market Share by Type in 2021 & 2028
• Figure 3. Interdigital Product Picture
• Figure 4. Vesicular Product Picture
• Figure 5. Global Tinea Pedis Treatment Market Share by Application in 2021 & 2028
• Figure 6. Hospital Pharmacies
• Figure 7. Retail Pharmacies
• Figure 8. Online Pharmacies
• Figure 9. Drug Stores
• Figure 10. Others
• Figure 11. Tinea Pedis Treatment Report Years Considered
• Figure 12. Global Tinea Pedis Treatment Sales 2017-2028 (K MT)
• Figure 13. Global Tinea Pedis Treatment Revenue, (US$ Million), 2017 VS 2021 VS 2028
• Figure 14. Global Tinea Pedis Treatment Revenue 2017-2028 (US$ Million)
• Figure 15. Global Tinea Pedis Treatment Revenue Market Share by Region in Percentage: 2021 Versus 2028
• Figure 16. Global Tinea Pedis Treatment Sales Market Share by Region (2017-2022)
• Figure 17. Global Tinea Pedis Treatment Sales Market Share by Region (2023-2028)
• Figure 18. North America Tinea Pedis Treatment Sales YoY (2017-2028) & (K MT)
• Figure 19. North America Tinea Pedis Treatment Revenue YoY (2017-2028) & (US$ Million)
• Figure 20. Europe Tinea Pedis Treatment Sales YoY (2017-2028) & (K MT)
• Figure 21. Europe Tinea Pedis Treatment Revenue YoY (2017-2028) & (US$ Million)
• Figure 22. Asia-Pacific Tinea Pedis Treatment Sales YoY (2017-2028) & (K MT)
• Figure 23. Asia-Pacific Tinea Pedis Treatment Revenue YoY (2017-2028) & (US$ Million)
• Figure 24. Latin America Tinea Pedis Treatment Sales YoY (2017-2028) & (K MT)
• Figure 25. Latin America Tinea Pedis Treatment Revenue YoY (2017-2028) & (US$ Million)
• Figure 26. Middle East & Africa Tinea Pedis Treatment Sales YoY (2017-2028) & (K MT)
• Figure 27. Middle East & Africa Tinea Pedis Treatment Revenue YoY (2017-2028) & (US$ Million)
• Figure 28. The Tinea Pedis Treatment Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
• Figure 29. The Top 5 and 10 Largest Manufacturers of Tinea Pedis Treatment in the World: Market Share by Tinea Pedis Treatment Revenue in 2021
• Figure 30. Global Tinea Pedis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
• Figure 31. Global Tinea Pedis Treatment Sales Market Share by Type (2017-2028)
• Figure 32. Global Tinea Pedis Treatment Revenue Market Share by Type (2017-2028)
• Figure 33. Global Tinea Pedis Treatment Sales Market Share by Application (2017-2028)
• Figure 34. Global Tinea Pedis Treatment Revenue Market Share by Application (2017-2028)
• Figure 35. North America Tinea Pedis Treatment Sales Market Share by Type (2017-2028)
• Figure 36. North America Tinea Pedis Treatment Revenue Market Share by Type (2017-2028)
• Figure 37. North America Tinea Pedis Treatment Sales Market Share by Application (2017-2028)
• Figure 38. North America Tinea Pedis Treatment Revenue Market Share by Application (2017-2028)
• Figure 39. North America Tinea Pedis Treatment Sales Share by Country (2017-2028)
• Figure 40. North America Tinea Pedis Treatment Revenue Share by Country (2017-2028)
• Figure 41. U.S. Tinea Pedis Treatment Revenue (2017-2028) & (US$ Million)
• Figure 42. Canada Tinea Pedis Treatment Revenue (2017-2028) & (US$ Million)
• Figure 43. Europe Tinea Pedis Treatment Sales Market Share by Type (2017-2028)
• Figure 44. Europe Tinea Pedis Treatment Revenue Market Share by Type (2017-2028)
• Figure 45. Europe Tinea Pedis Treatment Sales Market Share by Application (2017-2028)
• Figure 46. Europe Tinea Pedis Treatment Revenue Market Share by Application (2017-2028)
• Figure 47. Europe Tinea Pedis Treatment Sales Share by Country (2017-2028)
• Figure 48. Europe Tinea Pedis Treatment Revenue Share by Country (2017-2028)
• Figure 49. Germany Tinea Pedis Treatment Revenue (2017-2028) & (US$ Million)
• Figure 50. France Tinea Pedis Treatment Revenue (2017-2028) & (US$ Million)
• Figure 51. U.K. Tinea Pedis Treatment Revenue (2017-2028) & (US$ Million)
• Figure 52. Italy Tinea Pedis Treatment Revenue (2017-2028) & (US$ Million)
• Figure 53. Russia Tinea Pedis Treatment Revenue (2017-2028) & (US$ Million)
• Figure 54. Asia Pacific Tinea Pedis Treatment Sales Market Share by Type (2017-2028)
• Figure 55. Asia Pacific Tinea Pedis Treatment Revenue Market Share by Type (2017-2028)
• Figure 56. Asia Pacific Tinea Pedis Treatment Sales Market Share by Application (2017-2028)
• Figure 57. Asia Pacific Tinea Pedis Treatment Revenue Market Share by Application (2017-2028)
• Figure 58. Asia Pacific Tinea Pedis Treatment Sales Share by Region (2017-2028)
• Figure 59. Asia Pacific Tinea Pedis Treatment Revenue Share by Region (2017-2028)
• Figure 60. China Tinea Pedis Treatment Revenue (2017-2028) & (US$ Million)
• Figure 61. Japan Tinea Pedis Treatment Revenue (2017-2028) & (US$ Million)
• Figure 62. South Korea Tinea Pedis Treatment Revenue (2017-2028) & (US$ Million)
• Figure 63. India Tinea Pedis Treatment Revenue (2017-2028) & (US$ Million)
• Figure 64. Australia Tinea Pedis Treatment Revenue (2017-2028) & (US$ Million)
• Figure 65. Taiwan Tinea Pedis Treatment Revenue (2017-2028) & (US$ Million)
• Figure 66. Indonesia Tinea Pedis Treatment Revenue (2017-2028) & (US$ Million)
• Figure 67. Thailand Tinea Pedis Treatment Revenue (2017-2028) & (US$ Million)
• Figure 68. Malaysia Tinea Pedis Treatment Revenue (2017-2028) & (US$ Million)
• Figure 69. Philippines Tinea Pedis Treatment Revenue (2017-2028) & (US$ Million)
• Figure 70. Latin America Tinea Pedis Treatment Sales Market Share by Type (2017-2028)
• Figure 71. Latin America Tinea Pedis Treatment Revenue Market Share by Type (2017-2028)
• Figure 72. Latin America Tinea Pedis Treatment Sales Market Share by Application (2017-2028)
• Figure 73. Latin America Tinea Pedis Treatment Revenue Market Share by Application (2017-2028)
• Figure 74. Latin America Tinea Pedis Treatment Sales Share by Country (2017-2028)
• Figure 75. Latin America Tinea Pedis Treatment Revenue Share by Country (2017-2028)
• Figure 76. Mexico Tinea Pedis Treatment Revenue (2017-2028) & (US$ Million)
• Figure 77. Brazil Tinea Pedis Treatment Revenue (2017-2028) & (US$ Million)
• Figure 78. Argentina Tinea Pedis Treatment Revenue (2017-2028) & (US$ Million)
• Figure 79. Middle East and Africa Tinea Pedis Treatment Sales Market Share by Type (2017-2028)
• Figure 80. Middle East and Africa Tinea Pedis Treatment Revenue Market Share by Type (2017-2028)
• Figure 81. Middle East and Africa Tinea Pedis Treatment Sales Market Share by Application (2017-2028)
• Figure 82. Middle East and Africa Tinea Pedis Treatment Revenue Market Share by Application (2017-2028)
• Figure 83. Middle East and Africa Tinea Pedis Treatment Sales Share by Country (2017-2028)
• Figure 84. Middle East and Africa Tinea Pedis Treatment Revenue Share by Country (2017-2028)
• Figure 85. Turkey Tinea Pedis Treatment Revenue (2017-2028) & (US$ Million)
• Figure 86. Saudi Arabia Tinea Pedis Treatment Revenue (2017-2028) & (US$ Million)
• Figure 87. U.A.E Tinea Pedis Treatment Revenue (2017-2028) & (US$ Million)
• Figure 88. Tinea Pedis Treatment Value Chain
• Figure 89. Tinea Pedis Treatment Production Process
• Figure 90. Channels of Distribution
• Figure 91. Distributors Profiles
• Figure 92. Bottom-up and Top-down Approaches for This Report
• Figure 93. Data Triangulation
• Figure 94. Key Executives Interviewed